Jun 10, 2020
Menarini Group Completes a Solid Year of Operating Performance
May 14, 2020
25th EHA Congress: Menarini Ricerche Discloses First Results From the Clinical Study on SEL24/MEN1703
Mar 16, 2020
Covid-19: Menarini Group Converts Production Plant to Produce and Donate Disinfectant Gel
Dec 09, 2019
61st ASH Congress 2019: Menarini Ricerche Presents the Latest Updates About the First In Human Clinical Trial of SEL24/MEN1703
Sep 23, 2019
ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer
Sep 12, 2019
Menarini: Elcin Barker Ergun Group CEO
Jun 28, 2019
Menarini Ricerche Announces Publication of Pre-clinical Data of the First-in-class Antibody-drug Conjugate MEN1309/OBT076, Currently in Phase I Clinical Development
May 23, 2019
Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology
Dec 21, 2018
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
Oct 25, 2018
Menarini Launches "Pills of Art"
Oct 12, 2018
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
Sep 19, 2018
Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting
Aug 06, 2018
Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA
Jun 01, 2018
Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018
Apr 13, 2018
Menarini Ricerche to Present the Most Recent Pre-clinical Data About the PI3K Inhibitor MEN1611 at the AACR Annual Meeting 2018
Mar 12, 2018
Menarini Hires Their 17,000th Employee
Jun 29, 2017
Menarini Increases Number of Members of the Board - for the First Time External Members In Majority
Jun 07, 2017
Menarini Expands its Capabilities for Antibody Drug Conjugate (ADC) Projects